Home/Filings/4/0001136261-22-000159
4//SEC Filing

Mehra Raj 4

Accession 0001136261-22-000159

CIK 0001017491other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 4:34 PM ET

Size

5.3 KB

Accession

0001136261-22-000159

Insider Transaction Report

Form 4
Period: 2022-03-31
Mehra Raj
DirectorSee Remarks10% Owner
Transactions
  • Purchase

    Common Stock

    2022-03-31$0.85/sh+66,667$56,8403,281,546 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Documents

1 file

Issuer

SEELOS THERAPEUTICS, INC.

CIK 0001017491

Entity typeother

Related Parties

1
  • filerCIK 0001757892

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:34 PM ET
Size
5.3 KB